Skip to main content

9th ISMERAD | Alpha Therapy: New approaches in radionuclide therapy

The Symposium is intended for:

  • Researchers and professionals active in the subfields of interest;
  • European and Belgian health authorities and regulators;
  • Radioisotope distributors and related transport companies
Register
ISMERAD 2024
26/04/2024

NH Gent Belfort
Hoogpoort 63
9000 Gent

English

Overview

The 9th Symposium on Medical Radioisotopes intends to:

• Provide information on the perspectives of the world production of medical radioisotopes during the years to come;
• Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery;
• Present breakthroughs in radiopharmacy and nuclear medicine;
• Introduce new industrial and research initiatives.

Topics

  • Session 1: Origin/production of alpha-emitters. Challenges for the future - Overview of the activities
  • Session 2: Logistics (waste management)
  • Session 3: Studies | Clinical Potential | Dosimetry
  • Session 4: The future

Programme

09:00    Registration and welcome coffee

09:30    Opening

  • Welcome: Hans Van De Maele, PC Secretary
  • Introduction: Bernard Ponsard, PC Chair
  • Formal Opening: Ignace Lemahieu, RUG

09:45    Opening talk

  • Lu-177 and the perspective of alpha therapy | Zéna Wimana, HUBruxelles

            Session 1: Origin/production of alpha-emitters. Challenges for the future – Overview of the activities

  • Ac-225 | Sven Van den Berghe, PanTera
  • At-211 | Matthijs Sevenois, Molecular Imaging & THerapy research group (MITH)
  • Pb-212 | Philippe Dasse, ARTBIO

11:00    Coffee break and poster session

11:30    Session 2: Logistics (waste management)  

  • Centralized radiopharmacies | Filip De Vos, Ghent University, Department of Radiopharmacy
  • Waste Management | Pascal Froment, Be.Sure
  • Drone Logistics – AEGLE project on drone logistics for radiopharmaceuticals | Hans Van De Maele, ORI Consult – AEGLE Drone Services

12:30    Poster session

  • Poster competition

13:00    Lunch

14:00    NPO's | Short introduction

  • ICPO
  • Oncidium
  • Rad4Med

14:30    Session 3: Studies / Clinical Potential / Dosimetry

  • Clinical Potential | Mike Sathekge, University of Pretoria
  • Challenges in Dosimetry | Michel Koole,KUL

15:15   Coffee break and poster session

15:45    Session 4: The future

  • Potential of Terbium-161 | Florian Rosar, Nuclear Medicine Physician, Department of Nuclear Medicine, Saarland University
  • PRISMAP: projects/preclinical studies REX on projects | Thomas Cocolios, KULeuven

16:30    Poster prize ceremony

  • Traditionally 3 prizes are given for the best posters, respectively 500, 350 and 150 €

16:45    Closing

  • Eric van Walle

16:50    Reception

Organisation

ISMERAD vzw

Preparation

Call for posters to the researchers in the field

Please submit the abstract(s) (20 to 30 lines, title and authors not included) for peer-review by mail to 

bernard [dot] ponsard [at] sckcen [dot] be (bernard[dot]ponsard[at]sckcen[dot]be)

&

h [dot] vandemaele [at] be-wis [dot] com (h[dot]vandemaele[at]be-wis[dot]com)

Indicate clearly who is the principal investigator. 

Deadline: March 31, 2024. 

The abstracts of the accepted posters will be published. Similarly to the previous editions, this time too, three prizes (respectively 500, 350 and 150 €) will be allotted for the best three posters.

Price

€200 - regular parcipants | € 175 Early Bird

€ 30 - students | € 25 Early Bird

 

Share this event